Heron Therapeutics
HRTX
#7239
Rank
€0.27 B
Marketcap
1,82 €
Share price
3.59%
Change (1 day)
71.66%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -1,12 €

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -1,06 €. In 2022 the company made an earnings per share (EPS) of -1,56 € an increase over its 2021 EPS that were of -2,03 €.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-1,12 €-28.51%
2022-1,56 €-23.11%
2021-2,03 €-10%
2020-2,26 €-0%
2019-2,26 €1.21%
2018-2,23 €-32.7%
2017-3,31 €-19.34%
2016-4,11 €54.76%
2015-2,65 €1.73%
2014-2,61 €-16.23%
2013-3,11 €91.67%
2012-1,62 €-31.45%
2011-2,37 €-27.06%
2010-3,25 €-43.75%
2009-5,78 €-57.33%
2008-13,54 €-82.92%
2007-79,23 €20.61%
2006-65,69 €175.76%
2005-23,82 €-21.43%
2004-30,32 €100%
2003-15,16 €-38.24%
2002-24,55 €161.54%
2001-9,38 €-106.46%
2000145,19 €2203.99%
19996,30 €839.73%
19980,67 €-105.48%
1997-12,25 €-88.16%
1996-103,44 €

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
1,17 €-211.11%🇮🇪 Ireland
0,13 €-111.97%🇺🇸 USA
-1,47 € 39.32%🇺🇸 USA
1,42 €-234.19%🇺🇸 USA
-1,49 € 41.03%🇺🇸 USA